ID

31876

Beschreibung

Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00847886

Link

https://clinicaltrials.gov/show/NCT00847886

Stichworte

Versionen (1)
  1. 06.10.18 06.10.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

6. Oktober 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Rheumatoid Arthritis NCT00847886

Englisch

Eligibility Rheumatoid Arthritis NCT00847886

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
males and females ≥ 18 years old
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
must be willing to practice 2 adequate methods of contraception for the duration of the study
Beschreibung

Contraceptive methods Quantity Willing

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0600109
rheumatoid arthritis present for at least 3 months; functional class i, ii, or iii as defined by acr criteria
Beschreibung

Rheumatoid Arthritis Functional Status Class Disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0598463
UMLS CUI [1,3]
C0456387
UMLS CUI [1,4]
C0872146
treatment with methotrexate (7.5 to 25 mg per week) for at least the last 3 months, and currently receiving stable dose methotrexate for at least one month prior to the start of the study
Beschreibung

Methotrexate U/week | Methotrexate Dose Stable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0560588
UMLS CUI [2,1]
C0025677
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
ability to provide written informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
women who are pregnant or nursing
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of other current inflammatory arthritis
Beschreibung

Arthritis Other

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003864
UMLS CUI [1,2]
C0205394
history of opportunistic infection
Beschreibung

Opportunistic Infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0029118
history of recurrent infections or current infection 2 weeks prior to start of study
Beschreibung

Recurrent infections | Communicable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0239998
UMLS CUI [2]
C0009450
presence of significant, uncontrolled medical problems
Beschreibung

Medical Problem Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1254481
UMLS CUI [1,2]
C0205318
treatment with any disease-modifying anti-rheumatoid drugs other than methotrexate within 4 weeks prior to start of study
Beschreibung

Antirheumatic Drugs, Disease-Modifying | Exception Methotrexate

Datentyp

boolean

Alias
UMLS CUI [1]
C0242708
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025677
use of chondroitin sulfate, glucosamine sulfate, minocycline, or matrix metalloproteinase inhibitors, h-2 blockers, proton pump inhibitors, or misoprostol within 4 weeks prior to study start
Beschreibung

Chondroitin Sulfates | Glucosamine Sulfate | Minocycline | Matrix Metalloproteinase Inhibitors | H2 blockers | Proton Pump Inhibitors | Misoprostol

Datentyp

boolean

Alias
UMLS CUI [1]
C0008466
UMLS CUI [2]
C0017720
UMLS CUI [3]
C0026187
UMLS CUI [4]
C1513016
UMLS CUI [5]
C0019593
UMLS CUI [6]
C0358591
UMLS CUI [7]
C0085174
receipt of live vaccine within 8 weeks prior to study start
Beschreibung

Live vaccine

Datentyp

boolean

Alias
UMLS CUI [1]
C0042211
rheumatoid arthritis, functional class iv as defined by acr criteria
Beschreibung

Rheumatoid Arthritis Functional Status Class

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0598463
UMLS CUI [1,3]
C0456387
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Rheumatoid Arthritis NCT00847886

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
males and females ≥ 18 years old
boolean
C0001779 (UMLS CUI [1])
Contraceptive methods Quantity Willing
Item
must be willing to practice 2 adequate methods of contraception for the duration of the study
boolean
C0700589 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
Rheumatoid Arthritis Functional Status Class Disease length
Item
rheumatoid arthritis present for at least 3 months; functional class i, ii, or iii as defined by acr criteria
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
C0872146 (UMLS CUI [1,4])
Methotrexate U/week | Methotrexate Dose Stable
Item
treatment with methotrexate (7.5 to 25 mg per week) for at least the last 3 months, and currently receiving stable dose methotrexate for at least one month prior to the start of the study
boolean
C0025677 (UMLS CUI [1,1])
C0560588 (UMLS CUI [1,2])
C0025677 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Informed Consent
Item
ability to provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
women who are pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Arthritis Other
Item
history of other current inflammatory arthritis
boolean
C0003864 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Opportunistic Infection
Item
history of opportunistic infection
boolean
C0029118 (UMLS CUI [1])
Recurrent infections | Communicable Disease
Item
history of recurrent infections or current infection 2 weeks prior to start of study
boolean
C0239998 (UMLS CUI [1])
C0009450 (UMLS CUI [2])
Medical Problem Uncontrolled
Item
presence of significant, uncontrolled medical problems
boolean
C1254481 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Antirheumatic Drugs, Disease-Modifying | Exception Methotrexate
Item
treatment with any disease-modifying anti-rheumatoid drugs other than methotrexate within 4 weeks prior to start of study
boolean
C0242708 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0025677 (UMLS CUI [2,2])
Chondroitin Sulfates | Glucosamine Sulfate | Minocycline | Matrix Metalloproteinase Inhibitors | H2 blockers | Proton Pump Inhibitors | Misoprostol
Item
use of chondroitin sulfate, glucosamine sulfate, minocycline, or matrix metalloproteinase inhibitors, h-2 blockers, proton pump inhibitors, or misoprostol within 4 weeks prior to study start
boolean
C0008466 (UMLS CUI [1])
C0017720 (UMLS CUI [2])
C0026187 (UMLS CUI [3])
C1513016 (UMLS CUI [4])
C0019593 (UMLS CUI [5])
C0358591 (UMLS CUI [6])
C0085174 (UMLS CUI [7])
Live vaccine
Item
receipt of live vaccine within 8 weeks prior to study start
boolean
C0042211 (UMLS CUI [1])
Rheumatoid Arthritis Functional Status Class
Item
rheumatoid arthritis, functional class iv as defined by acr criteria
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video